Open Access

Wnt signaling in regulation of biological functions of the nurse cell harboring Trichinella spp.

  • Magdalena Dabrowska1Email author,
  • Marek Skoneczny2,
  • Zbigniew Zielinski1 and
  • Wojciech Rode1
Parasites & Vectors20169:483

https://doi.org/10.1186/s13071-016-1770-4

Received: 28 June 2016

Accepted: 22 August 2016

Published: 2 September 2016

Abstract

Background

The nurse cell (NC) constitutes in mammalian skeletal muscles a confined intracellular niche to support the metabolic needs of muscle larvae of Trichinella spp. encapsulating species. The main biological functions of NC were identified as hypermitogenic growth arrest and pro-inflammatory phenotype, both inferred to depend on AP-1 (activator protein 1) transcription factor. Since those functions, as well as AP-1 activity, are known to be regulated among other pathways, also by Wnt (Wingless-Type of Mouse Mammary Tumor Virus Integration Site) signaling, transcription profiling of molecules participating in Wnt signaling cascades in NC, was performed.

Methods

Wnt signaling-involved gene expression level was measured by quantitative RT-PCR approach with the use of Qiagen RT2 Profiler PCR Arrays and complemented by that obtained by searching microarray data sets characterizing NC transcriptome.

Results

The genes involved in inhibition of canonical Wnt/β-catenin signaling cascade as well as leading to β-catenin degradation were found expressed in NC at high level, indicating inhibition of this cascade activity. High expression in NC of genes transmitting the signal of Wnt non-canonical signaling cascades leading to activation of AP-1 transcription factor, points to predominant role of non-canonical Wnt signaling in a long term maintenance of NC biological functions.

Conclusions

Canonical Wnt/β-catenin signaling cascade is postulated to play a role at the early stages of NC formation when muscle regeneration process is triggered. Following mis-differentiation of infected myofiber and setting of NC functional specificity, are inferred to be controlled among other pathways, by Wnt non-canonical signaling cascades.

Keywords

Trichinella spp.Nurse cellWnt signalingGrowth arrestInflammatory phenotypeAP-1 transcription factor

Background

The nurse cell (NC) constitutes an intracellular niche for the muscle larvae of parasitic nematode Trichinella spp. Its basic morphological structure, called cyst, is formed within mammalian striated muscles 20–28 days post-oral infection [1, 2]. Larva penetration into the muscles induces degeneration of infected myofiber, followed by its fusion with muscle satellite cells and commencement of regeneration process. However, eventually mis-differentiation takes place and part of the infected myofiber transforms into a non-muscular structure, the NC fulfilling larva metabolic requirements. NC-larva complex confined within a collagen capsule and surrounded by circulatory rete is stably maintained throughout the life span of the host [1]. NC is characterized by hypertrophy and 4 N DNA content [3, 4]. Based on transcription profiling NC growth arrest stage was identified as being of G1-like type accompanied by cellular senescence [5]. NC was also found to display antigen presentation capability and pro-inflammatory secretory phenotype [6].

Wnt signaling pathway plays an important role in morphogenesis and postnatal stem cell fate determination [7, 8]. Inhibition of canonical Wnt/β-catenin signaling is required for cell lineage differentiation but the cascade, if recapitulated in mature differentiated cellular systems, is associated with onset of various diseases, including neurodegeneration and malignancies [911]. A role in cellular senescence and aging-associated disorders have been ascribed to various Wnt ligands [1214]. Physiological responses to Wnt signaling are elicited by diverse cellular functions: cell survival, proliferation, apoptosis, differentiation, cell movement and immunological activities [15]. Wnt growth factors bind to transmembrane Frizzled (Fzd) receptors, belonging to G Protein-Coupled Receptor (GPCR) family [9]. The signal is subsequently transduced via three distinct routes: the canonical Wnt/β-catenin and two non-canonical Wnt/PCP (Planar Cell Polarity) and Wnt/Ca2+, signaling cascades [15, 16]. Particular Wnt ligand-Fzd receptor interactions are tissue- and process-specific. It is emphasized for Wnt signal transduction that various combinations of ligand-receptor complexes, as well as many regulatory loops and cross-talks, also with other signaling pathways, ultimately lead to a cell-specific type of response [17, 18]. Despite such a diversity, specifically Wnt 4, Wnt 5A and Wnt 11 ligands are considered to activate Wnt non-canonical cascades [18, 19]. Of note, Wnt 5A upregulation was demonstrated to occur in stimulated antigen-presenting cells, i.e. dendritic cells and macrophages [20]. In the case of canonical Wnt signaling route transcription of effector genes is activated by β-catenin transcription activation complex, and in the case of non-canonical Wnt signaling route, by AP-1 transcription factor [15].

As far as skeletal muscles are concerned, Wnt signaling is involved in myogenesis and muscle regeneration. Canonical Wnt/β-catenin signaling mediated by Wnt 1 and Wnt 7A ligands was shown to induce early myogenesis in mice [21]. Wnt 3A, Wnt 5A/5B and Wnt 7A/7B ligands signaling is considered critical for muscle regeneration, with myoblast differentiation and myotube fusion assumed to be affected [8]. Yet transient β-catenin activation, accompanying this process, is also viewed rather as a vestige from embryonic lineage, crucial for myogenesis but requiring inhibition for muscle regeneration to proceed [22].

As a cellular system, NC originates from muscle cells suspended during regeneration. Immunological activities with signaling pathways culminating at AP-1 transcription factor activation, were identified as its prominent biological functions [6]. Those characteristics should apparently be controlled by Wnt signaling. Additionally, Wnt 2 ligand was found in general analysis of NC transcriptome to be highly upregulated, in comparison to myoblastic cell line [5]. Therefore, the present scrutinized analysis was undertaken, of expression level of factors involved in Wnt signaling in NC, performed with the use of PCR arrays and supported by the search of microarray data sets [5]. The results point to a putative essential role of Wnt factors in setting of NC phenotype.

Methods

NC isolation

Trichinellosis in BALB/c mice, infected with Trichinella spiralis H2 human isolate, was exploited as previously described [23]. NCs were isolated from mice carrying 6 month-old infections by sequential muscle digestion, as earlier presented [5]. NC in a typical preparation is shown in Fig. 1.
Fig. 1

NC-Trichinella spiralis larva complex. The nuclei were visualized with Hoechst 33342 dye (Lonza). The image was taken with Nikon Optiphot-Z fluorescence microscope. Scale-bar: 100 μm

RT2 Profiler PCR Arrays

Qiagen kits were used at all steps. Total RNA was isolated with the use of RNaesy Mini kit, according to manufacturer’s instruction, with implementation of the RNase-Free DNase digestion step. RNA integrity was confirmed using Agilent 2100 BioAnalyzer. RT2 First Strand kit was used for reverse transcription. RT2 SYBR Green/ROX qPCR Master Mix was used for quantitative PCR on Qiagen RT2 Profiler PCR Array of Mouse Wnt Signaling Pathway. The run was performed on 7500 Sequence Detection System (Applied Biosystems), including all control reactions recommended by the arrays’ manufacturer. Target gene expression level was calculated according to Qiagen RT2 Profiler PCR Array handbook, applying the comparative threshold cycle (CT) method, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) used as a reference gene. It is given as 2exp-ΔCT (± average deviation for n = 2), where ΔCT is CT (target gene)-CT (GAPDH). The genes included into RT2 Profiler PCR Array whose threshold cycle fell above 35th cycle were excluded from data presentation.

Microarray data sets searching

In order to complement performed herein transcription profiling of Wnt signaling factors in NC, the previously obtained competitive microarray data sets [5], were searched for identifiers included in Qiagen RT2 Profiler PCR Array, as well as the identifiers not included in the PCR array but otherwise related to Wnt signaling. In the aforementioned competitive microarray analysis, the transcriptomes of C2C12 myoblasts and C2C12 myotubes served as referral systems to the NC transcriptome. In order to eliminate biological differences among NC preparations, four different preparations of NCs isolated from mice carrying 5 to 12 month-infections were exploited for competitive microarray analysis. Only the identifiers with differential gene expression level ≥ 2 accompanied by a P-value ≤ 0.05, were considered signaling pathway-eligible. Fold change in gene expression level in NC, in relation to C2C12 myoblasts or myotubes, was calculated form log2ratio value and is provided as the average of quadruplicates, accompanied by the P-values calculated by Student’s one-sample t-test. All parameters of statistical analysis, including log2ratio ± standard deviation (SD) as well as the t-values, are shown in Additional file 1: Table S1.

Results and discussion

Characteristics of NC formation process

The NC is a non-muscular structure originating from a few types of cells. During encapsulation of the larva lasting up to 28 days post-infection, the nuclei, mitochondria and basophilic cytoplasm (i.e. staining with haematoxylin in haematoxylin and eosin (H&E) staining protocol), of infected myofiber, degenerate with the signs of apoptosis and autocrine signaling by tumor necrosis factor α [24, 25]. Inhibition of transforming growth factor β signaling by c-Ski repressor was also shown to accompany this process [26]. Muscle satellite cells, fusing with the infected degenerating myofiber, become the main source of nuclei, mitochondria and eosinophilic cytoplasm (i.e. staining with eosin in H&E staining procedure), in the completely established NC at 3-month-old infection. Some nuclei of NC become hypertrophied at this stage, and infiltrating lymphocytes were also identified entrapped in the NC cytoplasm [27]. It should be noted that during NC formation two various kinds of cytoplasm, basophilic and eosinophilic, are separated by plasma membrane and the whole process in independent on p53 suppressor gene [2, 27, 28]. Analysis of NC transcriptome during the process of intracellular transformation (i.e. 23rd day post-infection), indicated activation of survival mechanism mediated by insulin-like growth factor 1 which may lead to induction of AP-1 transcription factor [29, 30]. Wnt 8A and 5B ligand expression was also found upregulated at this stage of NC development, as analyzed in the whole infected vs uninfected muscle tissue [29]. Wnt canonical signaling cascade inhibitory factor Dickkopf homolog 4 (DKK4 gene) [31], was also found upregulated in those settings [29]. These findings indicate that already at the stage of larva encapsulation Wnt signaling-involved factors shape NC functional specificity towards non-canonical Wnt signaling and AP-1 factor activation, serving to determine survival and immunological properties.

Inhibitory factors of canonical Wnt/β-catenin signaling cascade are expressed in fully established NC

A network of molecules participating in Wnt signaling, whose expression was detected in NC, is depicted in Fig. 2. Gene description and gene expression levels are shown in Table 1. In cells unstimulated by Wnt ligands, central molecule of this cascade, β-catenin (encoded by CTNNB1 gene), is known to remain in the cytoplasm in a phosphorylated form complexed with GSK3B and scaffolding factors APC and AXIN1 [32]. Apart from GSK3B, also casein kinases, represented in NC by CSNK1A1, CSNK1D and CSNK2A1, are known to phosphorylate β-catenin. Additionally, bound with protein phosphatases (PPP2CA, PPP2R1A and PPP2R5D subunits are expressed in NC), β-catenin is ubiqutinated in the presence of BTRC and driven for proteasomal degradation [32]. SENP2 peptidase is also known to participate in downregulation of β-catenin level [33, 34]. Assuming autocrine stimulation to occur, the Wnt/β-catenin signaling cascade can be activated in NC by Wnt 1, Wnt 2/2B, Wnt 3/3A, Wnt 6, Wnt 9A and Wnt 16. Upon stimulation of FZD receptors by Wnt ligands activated Dsh1/2 proteins (encoded by DVL1/2 genes), lead to inhibition of β-catenin phosphorylation. Unphosphorylated β-catenin translocates to the nucleus where it forms a transcription activation complex with TCF/LEF factors, additionally activated by EP300 and BCL9/PYGO1 complex [32]. FZD receptors 1 through 8, coreceptors LRP5/6, as well as DVL1/2, TCF3/7 and LEF1 genes, are expressed in NC, though TCF7 and LEF1 are down regulated in relation to C2C12 cellular systems. Numerous molecules known to inhibit β-catenin transcription activation complex, including TLE1/2, CTBP1/2, CTNNBIP1, as well as an effector, and simultaneously an inhibitor, of this cascade, NKD1 gene product [35], are expressed in NC. NKD1 expression is also very highly upregulated in relation to C2C12 myoblasts/myotubes. Of note, NKD1 is known to switch Wnt signaling from canonical to non-canonical Wnt/PCP cascade [36]. Apart from apparent inhibition of canonical Wnt/β-catenin signaling cascade in NC by intracellular factors, this cascade may also be inhibited at the plasma membrane level. KRM1 (alias KREMEN1), WIF1, FRZB (alias SFRP3) and SFRP1/2/4 gene products, expressed in NC, are known to inhibit Wnt signaling via interaction with LRP5/6 coreceptors (KRM1), binding to Wnt ligands (WIF1 and FRZB) or interaction with both Wnt ligands and Fzd receptors (SFRP1/2/4 factors) [37, 38]. Importance of an inhibitory route of canonical Wnt/β-catenin signaling in NC at the plasma membrane level is further stressed by very high upregulation of FRZB and high upregulation of WIF1 expression in NC, in relation to C2C12 myoblasts/myotubes. Of note is that Wnt 1 inducible signaling pathway protein 1 WISP1, known to display anti-apoptotic activity [39], is expressed in NC at the level significantly lower than in C2C12 cellular systems. Effector genes of canonical Wnt/β-catenin signaling cascade expressed in NC include factors involved in regulation of cell fate and inflammation: cyclins D, c-Myc, Fra1 (encoded by FOSL gene) and c-Jun, as well as angiogenic factor VEGFC [web.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes].
Fig. 2

Summary of interactions involved in Wnt signaling cascades inferred to regulate NC biological functions. Only the molecules whose expression was detected in NC by RT2 Profiler PCR Arrays and/or microarrays, are marked. Wnt signaling consensus pathway was complied from Wnt signaling pathway available at www.qiagen.com/pl/shop/genes-and-pathways/pathway-details/?pwid=474, Ingenuity Pathway Analysis software (www.ingenuity.com/products.ipa) and references [9, 15]. Sharp arrows indicate activatory interactions and blunt arrows indicate inhibitory interactions. Descriptions of molecule names are given in Table 1

Table 1

Expression in NC of molecules involved in Wnt signaling pathway. Gene expression level determined by RT2 Profiler PCR Arrays is given as 2−∆CT, and by competitive microarray approach as a fold change, increase or decrease (↓) in relation to C2C12 myoblasts and myotubes. Data analysis was performed as described under Methods section

GenBank accession number

Gene symbol

Description

Gene expression 2−∆CT (± AD, n = 2)

Fold change (P-value) in gene expression level in NC vs C2C12 Myoblasts/myotubes

NM_007462

APC

Adenomatous polyposis coli

2.92 ± 0.40

 

NM_009733

AXIN1

Axin1

0.14 ± 0.06

 

NM_029933

BCL9

B-cell CLL/lymphoma 9

0.16 ± 0.03

 

NM_009771

BTRC

Beta-transducin repeat containing protein

0.63 ± 0.04

 

NM_023465

CTNNBIP1

Catenin beta interacting protein 1

1.59 ± 0.01

/2.1 (0.00)

NM_007631

CCND1

Cyclin D1

4.40 ± 0.62

/9.5 (0.00)*

NM_009829

CCND2

Cyclin D2

19.33 ± 1.41

5.1 (0.00)*/7.8 (0.00)*

NM_007632

CCND3

Cyclin D3

2.37 ± 0.64

2.1 (0.01)/↓1.9 (0.01)

NM_146087

CSNK1A1

Casein kinase 1, alpha 1

3.85 ± 1.01

/↓2.1 (0.00)

NM_139059

CSNK1D

Casein kinase 1, delta

7.36 ± 1.33

 

NM_007788

CSNK2A1

Casein kinase 2, alpha 1 polypeptide

9.55 ± 0.80

↓2.9 (0.00)/↓3.4 (0.00)

NM_013502

CTBP1

C-terminal binding protein 1

0.38 ± 0.12

 

NM_009980

CTBP2

C-terminal binding protein 2

5.26 ± 0.17

/2.2 (0.01)

NM_007614

CTNNB1

Catenin (cadherin associated protein), beta 1

2.03 ± 0.40

 

NM_172464

DAAM1

Dishevelled associated activator of morphogenesis 1

5.13 ± 0.47

 

NM_010091

DVL1

Dishevelled 1, dsh homolog (Drosophila)

0.48 ± 0.13

/↓2.2 (0.00)

NM_007888

DVL2

Dishevelled 2, dsh homolog (Drosophila)

0.09 ± 0.04

 

NM_177821

EP300

E1A binding protein p300

0.22 ± 0.06

 

NM_010234

FOS

v-FOS murine viral oncogene homolog

 

116.7 (0.00)*/27.2 (0.00)*

NM_008036

FOSB

FBJ murine viral oncogene homolog

 

6.0 (0.00)*/5.5 (0.00)*

NM_010235

FOSL1

Fos-like antigen 1

1.36 ± 0.13

↓3.1 (0.00)/2.1 (0.01)

NM_011356

FRZB

Frizzled-related protein

8.25 ± 2.13

21.9 (0.00)/14.8 (0.00)

NM_021457

FZD1

Frizzled homolog 1 (Drosophila)

1.36 ± 0.46

3.6 (0.00)/

NM_020510

FZD2

Frizzled homolog 2 (Drosophila)

1.20 ± 0.77

 

NM_021458

FZD3

Frizzled homolog 3 (Drosophila)

0.39 ± 0.04

 

NM_008055

FZD4

Frizzled homolog 4 (Drosophila)

0.35 ± 0.00

3.6 (0.01)/

NM_022721

FZD5

Frizzled homolog 5 (Drosophila)

1.97 ± 0.26

 

NM_008056

FZD6

Frizzled homolog 6 (Drosophila)

0.22 ± 0.11

 

NM_008057

FZD7

Frizzled homolog 7 (Drosophila)

0.07 ± 0.04

 

NM_008058

FZD8

Frizzled homolog 8 (Drosophila)

0.02 ± 0.01

3.4 (0.00)/2.4 (0.03)

NM_019827

GSK3B

Glycogen synthase kinase 3 beta

0.75 ± 0.02

 

NM_010591

JUN

Jun oncogene

7.68 ± 2.99

1.9 (0.00)/

NM_010592

JUND

Jun-D proto-oncogene

 

2.5 (0.02)*/2.1 (0.02)*

NM_032396

KREMEN1

Kringle containing transmembrane protein 1

8.56 ± 0.19

 

NM_010703

LEF1

Lymphoid enhancer binding factor 1

0.01 ± 0.003

↓3.7 (0.00)/↓2.4 (0.04)

NM_008513

LRP5

Low density lipoprotein receptor-related protein 5

1.43 ± 0.63

3.4 (0.00)/3.9 (0.00)

NM_008514

LRP6

Low density lipoprotein receptor-related protein 6

1.44 ± 0.09

 

NM_011945

MAP3K1

MEKK1, MAP kinase kinase kinase 1

 

4.9 (0.00)*/6.7 (0.00)*

NM_011948

MAP3K4

MEKK4, MAP kinase kinase kinase 4

 

2.1 (0.00)*/2.0 (0.00)

NM_009158

MAPK10

JNK3, Jun-N terminal kinase

 

8.8 (0.00)*/6.8 (0.00)*

NM_010849

MYC

Myelocytomatosis oncogene

0.88 ± 0.14

↓4.7 (0.00)*/↓2.9 (0.01)*

NM_027280

NKD1

Naked cuticle 1 homolog (Drosophila)

0.37 ± 0.04

42.3 (0.00)/27.8 (0.00)

NM_008702

NLK

Nemo-like kinase

0.38 ± 0.01

 

NM_019411

PPP2CA

Protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform

15.79 ± 0.81

 

NM_016891

PPP2R1A

Protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform

10.09 ± 0.04

 

NM_009358

PPP2R5D

Protein phosphatase 2, regulatory subunit B (B56), delta isoform

0.75 ± 0.14

 

NM_008855

PRKCB1

Protein kinase C, beta 1

 

10.0 (0.01)*/6.7 (0.00)*

AK017901

PRKCE

Protein kinase C, epsilon

 

4.3 (0.01)*/4.4 (0.00)*

NM_008859

PRKCQ

Protein kinase C, theta

 

6.3 (0.00)*/4.6 (0.01)*

NM_008860

PRKCZ

Protein kinase C, zeta

 

14.6 (0.00)*/10.6 (0.00)*

NM_028116

PYGO1

Pygopus 1

0.38 ± 0.01

4.6 (0.00)/3.0 (0.01)

NM_133955

RHOU

Ras homolog gene family, member U

0.51 ± 0.16

/2.3 (0.00)

NM_029457

SENP2

SUMO/sentrin specific peptidase 2

1.88 ± 0.05

 

NM_013834

SFRP1

Secreted frizzled-related protein 1

0.09 ± 0.008

 

NM_009144

SFRP2

Secreted frizzled-related protein 2

0.02 ± 0.012

/↓5.4 (0.00)

NM_016687

SFRP4

Secreted frizzled-related protein 4

0.01 ± 0.003

 

NM_009332

TCF3

Transcription factor 7-like 1 (T-cell specific, HMG box)

1.31 ± 0.10

2.1 (0.02)/2.6 (0.00)

NM_009331

TCF7

Transcription factor 7, T-cell specific

0.46 ± 0.13

↓3.2 (0.00)/↓2.3 (0.01)

NM_011599

TLE1

Transducin-like enhancer of split 1

1.10 ± 0.27

 

NM_019725

TLE2

Transducin-like enhancer of split 2

0.005 ± 0.0022

 

NM_009506

VEGFC

Vascular endothelial growth factor C

 

5.3 (0.00)*/5.9 (0.00)*

NM_011915

WIF1

Wnt inhibitory factor 1

0.15 ± 0.02

6.4 (0.00)/2.5 (0.00)

NM_018865

WISP1

WNT1 inducible signaling pathway protein 1

2.22 ± 0.69

↓4.9 (0.00)/↓6.1 (0.00)

NM_021279

WNT1

Wingless-related MMTV integration site 1

0.003 ± 0.0011

 

NM_009519

WNT11

Wingless-related MMTV integration site 11

1.89 ± 0.22

6.5 (0.00)/4.1 (0.00)

NM_053116

WNT16

Wingless-related MMTV integration site 16

0.14 ± 0.01

5.6 (0.01)/3.3 (0.00)

NM_023653

WNT2

Wingless-related MMTV integration site 2

0.008 ± 0.0029

28.2 (0.00)*/21.9 (0.00)*

NM_009520

WNT2B

Wingless related MMTV integration site 2b

0.03 ± 0.001

 

NM_009521

WNT3

Wingless-related MMTV integration site 3

0.002 ± 0.0013

3.3 (0.01)/2.4 (0.00)

NM_009522

WNT3A

Wingless-related MMTV integration site 3A

0.004 ± 0.0022

 

NM_009523

WNT4

Wingless-related MMTV integration site 4

0.009 ± 0.0062

↓2.9 (0.00)/

NM_009524

WNT5A

Wingless-related MMTV integration site 5A

0.03 ± 0.011

4.8 (0.01)/3.0 (0.02)

NM_009525

WNT5B

Wingless-related MMTV integration site 5B

5.89 ± 2.90

9.9 (0.00)/7.7 (0.00)

NM_009526

WNT6

Wingless-related MMTV integration site 6

0.03 ± 0.008

↓2.8 (0.01)/

NM_139298

WNT9A

Wingless-type MMTV integration site 9A

0.01 ± 0.005

2.5 (0.00)/↓2.1 (0.00)

*Asterisks mark gene expression level, determined by microarray approach and reported previously in the context of other signaling pathway analyses [5, 6]

It is thus inferred that dominant expression in NC of molecules involved in β-catenin degradation as well as inhibition of canonical Wnt signal transduction and β-catenin-dependent transcription, indicate that even though could be operating, Wnt/β-catenin signaling cascade is inhibited. Expression of the cascade effector genes may have resulted from Wnt/β-catenin-activated transcription at the earlier stages of NC formation, but in fully established NC this regulation seems to be attributed rather to other signaling pathways.

Effector factors of non-canonical Wnt/PCP and Wnt/Ca2+ signaling cascades are expressed in fully established NC

A network of molecules participating in non-canonical Wnt signaling cascades, whose expression was detected in NC, is schematically depicted in Fig. 2, with gene descriptions and expression level values provided in Table 1. Non-canonical Wnt signaling was shown in various cellular systems to be stimulated by Wnt 1/11 and Wnt 5A ligands [15, 40, 41]. Wnt 11 and Wnt 5B are expressed in NC at the highest level among other Wnt ligands. Their expression, as well as the expression of Wnt 5A, is also upregulated in relation to C2C12 myoblasts/myotubes. Similar to the canonical cascade, activation of Wnt/PCP cascade occurs via phosphorylation of Dsh proteins [16]. In NC, the signal can be transduced downstream by DAAM1 factor and RHOU-MAP3K1/4-JNK3 axis, to induce cytoskeleton rearrangements. JNK3 can also be activated in NC via Ca2+ and protein kinase C axis, known to be activated also by classical GPCRs. JNK3 phosphorylates c-Jun and JunD which then dimerise with one of the Fos proteins to form transcription factor AP-1, known to display prosurvival and proinflammatory action, as well as to inhibit myogenesis [16, 4247]. Expression of c-Jun, JunD, Fra-1 (encoded by FOSL1 gene), FosB and Fos is found in NC, with Fos being the most highly upregulated gene in relation to C2C12 cellular systems. Thus expression in NC of Wnt 11, Wnt 5A/5B ligands, as well as JNK3 and Jun/Fos factors, indicate importance of AP-1 factor in maintenance of NC biological functions mediated by non-canonical Wnt signaling cascades. One of the effector genes of Wnt/Ca2+ signaling cascade, expressed in NC, is Nemo-like kinase (NLK, Table 1). As NLK is known to suppress β-catenin-dependent transcription [48], its expression in NC further points to inhibition of canonical Wnt signaling cascade.

It is inferred from the study performed that canonical, as well as non-canonical cascades operate in NC at the various stages of its formation. Expression in the fully established NC of Wnt ligands responsible for activation of canonical Wnt signaling cascade, the latter known to accompany induction of muscle regeneration [8, 22], may reflect the vestiges from those stages of NC formation when muscle regeneration was triggered. Eventually the cascade inhibition prevails. It is also possible that expression in fully established NC of the cascade inhibiting factors, including a feedback inhibitor NKD1, is indicative of execution of a tight control of the remaining activity of canonical Wnt signaling. It can be hypothesized that at the time point of larva penetration Wnt autocrine signaling may be responsible for β-catenin-dependent induction of infected myofiber regeneration. As no differentiation ultimately occurs, probably due to influence of EGF (epidermal growth factor)/FGF (fibroblast growth factor)/PDGF (platelet-derived growth factor)- induced proliferative stimulation [5], Wnt 5A/5B- and Wnt 11-activated non-canonical signaling cascades sustain the activation of AP-1 transcription factor to regulate NC growth arrest and immunological functions [6]. Current analysis was based on putative loops of autocrine signaling operating in NC. Parasite-derived factors and paracrine signaling should also control NC formation and the functioning of NC at fully established stage. Long-term maintenance of NC biological specificity apparently results from a precise orchestration of various cellular signaling events. The nature of the exact factor causing transformation of muscular cells to the parasite-favorable environment, remains to be identified.

Conclusions

The NC is an intracellular habitat for Trichinella spp. muscle larvae. Assuming autocrine signaling by Wnt ligands to occur during a long-term existence of the NC-Trichinella muscle larva complex, the canonical Wnt signaling cascade is inferred to be inhibited, but the non-canonical Wnt/PCP and Wnt/Ca2+ cascades are postulated to lead to maintenance of AP-1 transcription factor activation and execution of NC biological functions.

Abbreviations

AP-1: 

activator protein 1

EGF: 

epidermal growth factor

FGF: 

fibroblast growth factor

GAPDH: 

glyceraldehyde-3-phosphate dehydrogenase

GPCR: 

G protein–coupled receptor

H&E: 

haematoxylin and eosin

NC: 

nurse cell

PCP: 

planar cell polarity

PDGF: 

platelet-derived growth factor

Wnt: 

Wingless-type of mouse mammary tumor virus integration site

Declarations

Acknowledgements

Not applicable.

Funding

This study was supported by National Science Center grant no. 2011/01/B/NZ6/01781.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article and Additional file 1.

Authors’ contributions

MD performed NC isolation, PCR arrays and pathway analysis. MS performed microarray data analysis. ZZ carried out parasite culture. WR coordinated implementation of the project. All authors read and approved the final version of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Ethical approval for this study was granted by the First Warsaw Local Ethics Committee for Animal Experimentation at the Nencki Institute.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Laboratory of Comparative Enzymology, Department of Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences
(2)
Department of Genetics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences

References

  1. Despommier DD. How does Trichinella spiralis make itself at home? Parasitol Today. 1998;14:318–23.View ArticlePubMedGoogle Scholar
  2. Boonmars T, Wu Z, Nagano I, Takahashi Y. What is the role of p53 during the cyst formation of Trichinella spiralis? A comparable study between knockout mice and wild type mouse. Parasitology. 2005;131:705–12.View ArticlePubMedGoogle Scholar
  3. Jasmer DP. Trichinella spiralis infected muscle cells arrest in G2/M and cease muscle gene expression. J Cell Biol. 1993;121:785–93.View ArticlePubMedGoogle Scholar
  4. Jasmer DP. Trichinella spiralis: subversion of differentiated mammalian skeletal muscle cells. Parasitol Today. 1995;11:185–8.View ArticleGoogle Scholar
  5. Dabrowska M, Skoneczny M, Zielinski Z, Rode W. Nurse cell of Trichinella spp. as a model of long-term cell cycle arrest. Cell Cycle. 2008;7:2167–78.View ArticlePubMedGoogle Scholar
  6. Dabrowska M. Inflammatory phenotype of the nurse cell harboring Trichinella spp. Vet Parasitol. 2013;194:150–4.View ArticlePubMedGoogle Scholar
  7. van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development. 2009;136:3205–14.View ArticlePubMedGoogle Scholar
  8. Tsivitse S. Notch and Wnt signaling, physiological stimuli and postnatal myogenesis. Int J Biol Sci. 2010;6:268–81.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Anastas JN, Moon RT. WNT signaling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11–26.View ArticlePubMedGoogle Scholar
  10. Powers S, Mu D. Genetic similarities between organogenesis and tumorigenesis of the lung. Cell Cycle. 2008;2:200–4.View ArticleGoogle Scholar
  11. Verani R, Cappuccio I, Spinsanti P, Gradini R, Caruso A, Magnotti MC. Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid. J Neurochem. 2007;100:242–50.View ArticlePubMedGoogle Scholar
  12. Ye X, Zerlanko B, Kennedy A, Banumathy G, Zhang R, Adams PD. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol Cell. 2007;27:183–96.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007;317:803–6.View ArticlePubMedGoogle Scholar
  14. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317:807–10.View ArticlePubMedGoogle Scholar
  15. Staal FJT, Tiago CL, Tiemessen MM. WNT signaling in the immune system: WNT is spreading its wings. Nat Rev Immunol. 2008;8:581–93.View ArticleGoogle Scholar
  16. Lai S-L, Chien AJ, Moon RT. Wnt/Fzd signaling and the cytoskeleton: potential roles in tumorigenesis. Cell Res. 2009;19:532–45.View ArticlePubMedGoogle Scholar
  17. Niehrs C. The complex world of WNT receptor signaling. Nat Rev Mol Cell Biol. 2012;13:767–79.View ArticlePubMedGoogle Scholar
  18. Nusse R. Wnt signaling in disease and in development. Cell Res. 2005;15:28–32.View ArticlePubMedGoogle Scholar
  19. Schlessinger K, Hall A, Tolwinski N. Wnt signaling pathways meet Rho GTPases. Genes Dev. 2009;23:265–77.View ArticleGoogle Scholar
  20. Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol. 2007;82:710–20.View ArticlePubMedGoogle Scholar
  21. Bryson-Richardson RJ, Currie PD. The genetics of vertebrate myogenesis. Nat Rev Genet. 2008;9:632–46.View ArticlePubMedGoogle Scholar
  22. Murphy MM, Keefe AC, Lawson JA, Flygare SD, Yandell M, Kardon G. Transiently active Wnt/β-catenin signaling is not required but must be silenced for stem cell function during muscle regeneration. Stem Cell Rep. 2014;3:475–88.View ArticleGoogle Scholar
  23. Dabrowska M, Zielinski Z, Wranicz M, Michalski R, Pawelczak K, Rode W. Trichinella spiralis thymidylate synthase: developmental pattern, isolation, molecular properties, and inhibition by substrate and cofactor analogues. Biochem Biophys Res Commun. 1996;228:440–5.View ArticlePubMedGoogle Scholar
  24. Boonmars T, Wu Z, Nagano I, Takahashi Y. Expression of apoptosis-related factors in muscles infected with Trichinella spiralis. Parasitology. 2004;128:323–32.View ArticlePubMedGoogle Scholar
  25. Wu Z, Nagano I, Boonmars T, Takahashi Y. Tumor necrosis factor receptor-mediated apoptosis in Trichinella spiralis-infected muscle cells. Parasitology. 2005;131:373–81.View ArticlePubMedGoogle Scholar
  26. Wu Z, Nagano I, Boonmars T, Takahashi Y. Involvement of the c-Ski oncoprotein in cell cycle arrest and transformation during nurse cell formation after Trichinella spiralis infection. Int J Parasitol. 2006;36:1159–66.View ArticlePubMedGoogle Scholar
  27. Matsuo A, Wu Z, Nagano I, Takahashi Y. Five types of nuclei present in the capsule of Trichinella spiralis. Parasitology. 2000;121:203–10.View ArticlePubMedGoogle Scholar
  28. Wu Z, Matsuo A, Nakada T, Nagano I, Takahashi Y. Different response of satellite cells in the kinetics of myogenic regulatory factors and ultrastructural pathology after Trichinella spiralis and T. pseudospiralis infection. Parasitology. 2001;123:85–94.View ArticlePubMedGoogle Scholar
  29. Wu Z, Nagano I, Boonmars T, Takahashi Y. A spectrum of functional genes mobilized after Trichinella spiralis infection in skeletal muscle. Parasitology. 2005;130:561–73.View ArticlePubMedGoogle Scholar
  30. Wu Z, Sofronic-Milosavljevic L, Nagano I, Takahashi Y. Trichinella spiralis: nurse cell formation with emphasis on analogy to muscle cell repair. Parasit Vectors. 2008;1:27.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Zorn AM. Wnt signaling: Antagonistic Dickkopfs. Curr Biol. 2001;11:R592–5.View ArticlePubMedGoogle Scholar
  32. Mosimann C, Hausmann G, Baster K. β-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol. 2009;10:276–86.View ArticlePubMedGoogle Scholar
  33. Kadoya T, Kishida S, Fukui A, Hinoi T, Michiue T, Asashima M, Kikuchi A. Inhibition of Wnt signaling pathway by a novel axin-binding protein. J Biol Chem. 2000;275:37030–7.View ArticlePubMedGoogle Scholar
  34. Nishida T, Kanedo F, Kitagawa M, Yasuda H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting β-catenin degradation. J Biol Chem. 2001;276:39060–6.View ArticlePubMedGoogle Scholar
  35. Angonin D, Van Raay TJ. Nkd1 functions as a passive antagonist of Wnt signaling. PLoS One. 2013;8:e74666.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Katoh M. WNT/PCP signaling pathway and human cancer. Oncol Rep. 2005;14:1583–8.PubMedGoogle Scholar
  37. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149:1192–205.View ArticlePubMedGoogle Scholar
  38. Mao B, Wu W, Davidson G, Marhold J, Li M, Melcher BM, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signaling. Nature. 2002;417:664–7.View ArticlePubMedGoogle Scholar
  39. Su F, Overholtzer M, Besser D, Levine AJ. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev. 2002;16:46–57.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Tao E, Pennica D, Xu L, Kalejta RF, Levine AJ. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev. 2001;15:1796–807.View ArticlePubMedPubMed CentralGoogle Scholar
  41. De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin. 2011;43:754–6.View ArticleGoogle Scholar
  42. Conejo R, Valverde AM, Banito M, Lorenzo M. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kB and downregulation of AP1 activities. J Cell Physiol. 2001;186:82–94.View ArticlePubMedGoogle Scholar
  43. Johnson GL, Nakamura K. The c-Jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim Biophys Acta. 2007;1773:1341–8.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Kallunki T, Deng T, Hibi M, Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 1996;87:929–39.View ArticlePubMedGoogle Scholar
  45. Li M-D, Yang X. A retrospective on nuclear receptor regulation of inflammation: lessons from GR and PPARs. PPAR Res. 2011;2011:742785.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012;4:a006049.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Park K, Chung M, Kim S-J. Inhibition of myogenesis by okadaic acid, an inhibitor of protein phosphatases, 1 and 2A, correlates with the induction of AP1. J Biol Chem. 1992;267:10810–5.PubMedGoogle Scholar
  48. Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of β-catenin in mice. Genes Dev. 2008;22:2308–41.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement